Range
3.85 - 3.99
Vol / Avg.
1.1M/3M
Div / Yield
-
52 Wk
2.45 - 7.94
Mkt Cap
260.8M
Payout Ratio
-
Open
3.94
P/E
-
EPS
-0.41
Shares
66.4M
Outstanding
66.4M
Total Float
-
Benzinga - Jun 4, 2021, 4:34AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations. Its pipeline products are Diazepam, Pramlintide-Insulin, Self-Administered Glucagon, and others.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.340-0.300 0.0400
REV7.470M8.051M581.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
XERSXeris Pharmaceuticals-0.51%260.8M

Xeris Pharmaceuticals Frequently Asked Questions

Q

How do I buy Xeris Pharmaceuticals (XERS) stock?

A

You can purchase shares of Xeris Pharmaceuticals (NASDAQ: XERS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Xeris Pharmaceuticals's (XERS) competitors?

Q

What is the target price for Xeris Pharmaceuticals (XERS) stock?

A

The latest price target for Xeris Pharmaceuticals (NASDAQ: XERS) was reported by Mizuho on April 23, 2020. The analyst firm set a price target for 14.00 expecting XERS to rise to within 12 months (a possible 256.23% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Xeris Pharmaceuticals (XERS)?

A

The stock price for Xeris Pharmaceuticals (NASDAQ: XERS) is $3.93 last updated Today at 7:36:31 PM.

Q

Does Xeris Pharmaceuticals (XERS) pay a dividend?

A

There are no upcoming dividends for Xeris Pharmaceuticals.

Q

When is Xeris Pharmaceuticals (NASDAQ:XERS) reporting earnings?

A
Xeris Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Xeris Pharmaceuticals (XERS) going to split?

A

There is no upcoming split for Xeris Pharmaceuticals.

Q

What sector and industry does Xeris Pharmaceuticals (XERS) operate in?

A

Xeris Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.